Mylan Announces Strategic Collaboration With Biocon To Enter The Global Generic Biologics Market

Published June 29, 2009, 10:46 pm, BioresearchOnline

Mylan Inc. (Nasdaq: MYL ) today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace.

Discover News | Full Story